Amino acid substitutions at position 69 of the reverse transcriptase of human immunodeficiency virus type 1 are frequent in zalcitabine-naive antiretroviral-drug-experienced patients.
Brigitte
B
Montes
Michel
M
Segondy
D019943:Amino Acid Substitution / Q000235:genetics*; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D024882:Drug Resistance, Viral; D054303:HIV Reverse Transcriptase / Q000235:genetics*; D015497:HIV-1 / Q000201:enzymology* / Q000235:genetics*; D006801:Humans; D016015:Logistic Models; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D016047:Zalcitabine / Q000627:therapeutic use*
D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors; D016047:Zalcitabine; D054303:HIV Reverse Transcriptase